Advertisement

Nitroglycerin in experimental myocardial infarction effects on regional left ventricular length and tension

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Controversy has existed concerning the value of nitroglycerin therapy in acute myocardial infarction. With use of Walton-Brodie strain gauge arches and mercury-in-Silastic segment length gauges, the effects of nitroglycerin (30 μg/kg intravenously) were studied on local tension and length characteristics of the ischemic, border and nonischemic zones of the left ventricle in 10 open chest dogs. In the nonischemic zone total tension increased to 144.8 ± 13.6 (mean ± standard error of the mean) percent (P <0.005) of control levels, and segment length decreased to 79.4 ± 4.4 percent (P <0.01) with infusion of nitroglycerin 15 to 30 minutes after coronary ligation. Changes were similar in the groups given nitroglycerin 45 to 60 minutes and 2 to 3 hours after ligation. The border zone exhibited an increase in total tension to 132.3 ± 8.4 percent (P <0.005) of control level and a decrease in segment length to 79.0 ± 2.4 percent (P <0.001) in the 15 to 30 minute group. In the 45 to 60 minute group, tension increased to 117.9 ± 4.8 percent (P <0.005), whereas length decreased to 86.8 ± 1.4 percent (P <0.001); and in the 2 to 3 hour group tension increased to 124.9 ± 6.0 percent (P <0.005), and length decreased to 91.9 ± 3.5 percent (P <0.001). The decrease in magnitude of responsiveness in the 45 to 60 minute and 2 to 3 hour postligation groups compared with the 15 to 30 minute postligation group was highly significant (P <0.005). The central ischemic zone showed no significant change in tension or length in any group. Maximal response to nitroglycerin administration in both tension and length parameters was observed within 30 to 60 seconds and was concomitant with a decrease in systolic pressure to 73.3 ± 1.9 percent (P <0.001) and an increase in heart rate to 107.2 ± 1.0 percent.
      Nitroglycerin improves the contractile performance of the nonischemic and border zones after coronary occlusion without affecting the central ischemic zone. However, the border zone exhibits a progressive decrease in contractile response as a function of time. These data suggest that nitroglycerin has the overall effect of functionally reducing the extent of the ischemic area and strongly supports its potential clinical usefulness in acute myocardial infarction.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Russek HI
        • Urbach KF
        • Zohman BL
        Paradoxical action of glyceryl trinitrate (nitroglycerin) in coronary patients.
        JAMA. 1955; 158: 1017-1021
        • Smith ER
        • Redwood DR
        • McCarron WE
        • et al.
        Coronary artery occlusion in conscious dog: effects of alterations in arterial pressure produced by nitroglycerin, hemorrhage and alpha-adrenergic agonists on the degree of myocardial ischemia.
        Cirulation. 1973; 47: 51-57
        • Darby TD
        • Sprouse JH
        • Walton RP
        Evaluation of sympathetic reflex effects on the inotropic action of nitroglycerin, quinidine, papaverine, aminophylline and isoproterenol.
        J Pharmacol Exp Ther. 1958; 122: 386-395
        • Gold HK
        • Leinbach RC
        • Sanders CA
        Use of sublingual nitroglycerin in congestive failure following acute myocardial infarction.
        Circulation. 1972; 46: 839-845
        • Flaherty J
        • Reid P
        • Kelly D
        • et al.
        Intravenous nitroglycerin in acute myocardial infarction.
        Circulation. 1973; 48 (abstr): IV-104
        • Pine R
        • Meister SG
        • Banka VS
        • et al.
        Use of nitroglycerin to unmask reversibility of ventricular contraction abnormalities due to coronary disease.
        Clin Res. 1973; 21 (abstr): 442
        • Pine R
        • Meister SG
        • Banka VS
        • et al.
        Detection of reversible contraction abnormalities with nitroglycerin: correlation with postcoronary bypass ventriculography.
        Circulation. 1973; 48 (abstr): IV-104
        • Helfant RH
        • Pine R
        • Meister SG
        • et al.
        Nitroglycerin to unmask reversible asynergy: correlation with postcoronary bypass ventriculography.
        Circulation. 1974; 50: 108-113
        • Banka VS
        • Helfant RH
        Temporal sequence of dynamic contractile characteristics of ischemic and nonischemic myocardium following acute coronary ligation.
        Am J Cardiol. 1974; 34: 158-163
        • Nakhjavan FK
        • Son R
        • Goldberg H
        Myocardial contractility in areas with chronic ischemia: studies on isometric tension.
        Cardiovasc Res. 1968; 3: 226-233
        • Hood WB
        • Covelli VH
        • Abelmann WH
        • et al.
        Persistence of contractile behavior in acutely ischemic myocardium.
        Cardiovasc Res. 1969; 3: 249-260
        • Cotten MdeV
        • Bay E
        Direct measurement of changes in cardiac contractile force.
        Am J Physiol. 1956; 187: 122-134
        • Weiner L
        • Dwyer Jr, EM
        • Cox JW
        Hemodynamic effects of nitroglycerin, propranolol, and their combination in coronary heart disease.
        Circulation. 1969; 39: 623-632
        • Brachfeld N
        • Bozer J
        • Gorlin R
        Action of nitroglycerin on coronary circulation in normal and in mild cardiac subjects.
        Circulation. 1959; 19: 697-704
        • Sonnenblick EH
        • Skelton CL
        Myocardial energetics: basic principles and clinical implications.
        N Engl J Med. 1971; 285: 668-675
        • Goldstein RE
        • Stinson EB
        • Scherer JL
        • et al.
        Intraoperative coronary collateral function in patients with coronary occlusive disease: nitroglycerin responsiveness and angiographic correlations.
        Circulation. 1974; 49: 298-308
        • Walton RP
        • Cotten MdeV
        • Brill HH
        • et al.
        Factors influencing measurement of contractile force of heart muscle in situ.
        Am J Physiol. 1950; 161: 489-504